Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,755,881 papers from all fields of science
Search
Sign In
Create Free Account
Sesterterpenes
Known as:
Sesterterpenes [Chemical/Ingredient]
Terpenes of five units of HEMITERPENES, formed from geranylfarnesyl pyrophosphate.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
50 relations
Narrower (42)
12-acetoxy dendrillolide A
16-deacetoxy-12-epi-scalarafuranacetate
3-anhydro-6-hydroxyophiobolin A
DSF-52
Expand
In Blood
Process of secretion
agonists
antagonists & inhibitors
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Cytotoxic Scalarane Sesterterpenes from the Sponge Hyrtios erectus
Oh-Seok Kwon
,
Donghwa Kim
,
+6 authors
Jongheon Shin
Marine Drugs
2020
Corpus ID: 218658391
Twelve new sesterterpenes along with eight known sesterterpenes were isolated from the marine sponge Hyrtios erectus collected…
Expand
2016
2016
Cytotoxic scalarane-type sesterterpenes from the Saudi Red Sea sponge Hyrtios erectus
W. Alarif
,
S. Al-Lihaibi
,
Mohamed A Ghandourah
,
Mohamed I. Orif
,
S. Basaif
,
S. Ayyad
Journal of Asian natural products research
2016
Corpus ID: 24592871
Abstract The CHCl3/MeOH extract of the marine sponge Hyrtios erectus showed cytotoxicity against three cancer cell lines HepG2…
Expand
2014
2014
Suvanine Sesterterpenes from a Tropical Sponge Coscinoderma sp. Inhibit Isocitrate Lyase in the Glyoxylate Cycle
So-Hyoung Lee
,
T. H. Won
,
Heegyu Kim
,
Chan-Hong Ahn
,
Jongheon Shin
,
K. Oh
Marine Drugs
2014
Corpus ID: 1736573
The glyoxylate cycle is a sequence of anaplerotic reactions catalyzed by the key enzymes isocitrate lyase (ICL) and malate…
Expand
2005
2005
Biodiversity as a source of new pharmacophores: A new theory of memory III
Atta-ur-rahman
,
M. Choudhary
2005
Corpus ID: 98456568
Abstract Several classes of natural products with significant inhibitory activity against target enzymes involved in several…
Expand
2001
2001
Differentiation in chronic myelogenous leukemia cell K562 by spongean sesterterpene.
S. Aoki
,
K. Higuchi
,
+5 authors
Motomasa Kobayashi
Biochemical and Biophysical Research…
2001
Corpus ID: 45310914
Scalarane-type sesterterpenes, PHC-1-PHC-7, which have been isolated from a marine sponge, increased hemoglobin production in…
Expand
2000
2000
Scalarane-based sesterterpenes from an Indonesian sponge Strepsichordaia aliena.
Jorge I. Jiménez
,
Wesley Y. Yoshida
,
P. Scheuer
,
M. Kelly
Journal of Natural Products
2000
Corpus ID: 23834414
Investigation of the lipophilic extract of the sponge Strepsichordaia aliena revealed six new 20,24-bishomoscalarane…
Expand
1999
1999
Search for new compounds and biologically active substances from Chinese marine organisms
L. Zeng
,
J. Su
,
+8 authors
G. Wang
1999
Corpus ID: 43994529
Abstract
1998
1998
Antineoplastic agents. 397: Isolation and structure of sesterstatins 4 and 5 from Hyrtios erecta (the Republic of Maldives).
George R. Pettit
,
R. Tan
,
+5 authors
J. Chapuis
Bioorganic & Medicinal Chemistry Letters
1998
Corpus ID: 20933876
1994
1994
Marine natural products. XXXII. Absolute configurations of C-4 of the manoalide family, biologically active sesterterpenes from the marine sponge Hyrtios erecta.
M. Kobayashi
,
T. Okamoto
,
K. Hayashi
,
N. Yokoyama
,
T. Sasaki
,
I. Kitagawa
Chemical and pharmaceutical bulletin
1994
Corpus ID: 37523226
Cytotoxic sesterterpenes, manoalide 25-acetals (1a, 1b), seco-manoalide (2), (E)-neomanoalide (3), (Z)-neomanoalide (4), and…
Expand
1988
1988
Sesterterpenes from a Pacific sponge, Carteriospongia flabellifera.
Francis J. Schmitz
,
James C. Chang
Journal of Natural Products
1988
Corpus ID: 6414078
12,13-Didehydrofurospongin-1 and 16 beta-acetoxy-24-methyl-12,24-dioxosclaran-25-al, C21 and C26 sesterterpenes, were isolated…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE